{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:48:01Z","timestamp":1792806481166,"version":"4.5.0"},"reference-count":121,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2020,1,5]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>Sarcoidosis affects the nervous system in 10% of cases. When it does so it can affect any part of the nervous system and with all degrees of severity. It forms part of the differential diagnosis in inflammatory, infective, neoplastic and degenerative neurological diseases and may be very difficult to diagnose without histological confirmation. Recent clinical studies and the increasing availability of new biological treatments allow a much clearer understanding of the disease. This review summarises its clinical features, imaging and laboratory characteristics, treatment and outcome.<\/jats:p>","DOI":"10.1136\/practneurol-2019-002349","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T05:55:17Z","timestamp":1589781317000},"page":"199-212","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":72,"title":["Neurosarcoidosis: clinical manifestations, investigation and treatment"],"prefix":"10.1136","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2415-9011","authenticated-orcid":false,"given":"Desmond P","family":"Kidd","sequence":"first","affiliation":[{"name":"Centre for Neurosarcoidosis, Neuroimmunology unit, Institute of Immunology and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,17]]},"reference":[{"key":"2025090409225408000_20.3.199.1","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"2001","author":"Baughman","year":"1889","journal-title":"Am J Respir Crit Care Med"},{"key":"2025090409225408000_20.3.199.2","first-page":"204","article-title":"Two year prognosis of sarcoidosis: the access experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025090409225408000_20.3.199.3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2025090409225408000_20.3.199.4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/2040622318790197","article-title":"Epidemiology of sarcoidosis: current findings and future directions","volume":"9","author":"Arkema","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"key":"2025090409225408000_20.3.199.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-018-0871-3","article-title":"Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study","volume":"19","author":"Yoon","year":"2018","journal-title":"Respir Res"},{"key":"2025090409225408000_20.3.199.6","first-page":"61","article-title":"The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study","volume":"12","author":"Pietinalho","year":"1995","journal-title":"Sarcoidosis"},{"key":"2025090409225408000_20.3.199.7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00075307"},{"key":"2025090409225408000_20.3.199.8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1346-8138.13654","article-title":"Comorbid autoimmune disease in patients with sarcoidosis: a nationwide case-control study in Taiwan","volume":"44","author":"CH","year":"2017","journal-title":"J Dermatol"},{"key":"2025090409225408000_20.3.199.9","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009096"},{"key":"2025090409225408000_20.3.199.10","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-760OC"},{"key":"2025090409225408000_20.3.199.11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00477-2016"},{"key":"2025090409225408000_20.3.199.12","doi-asserted-by":"crossref","unstructured":"Ungprasert P , Carmona EM , Utz JP , et al . Epidemiology of sarcoidosis 1946 \u2013 2013: a population-based study. Mayo Clin Proc 2016:183\u20138.","DOI":"10.1016\/j.mayocp.2015.10.024"},{"key":"2025090409225408000_20.3.199.13","doi-asserted-by":"publisher","DOI":"10.1136\/thx.40.4.284"},{"key":"2025090409225408000_20.3.199.14","first-page":"22","article-title":"The epidemiology of systemic sarcoidosis in eastern Hertfordshire, UK","volume":"2","author":"Kidd","year":"2018","journal-title":"Annals of Public Health Reports"},{"key":"2025090409225408000_20.3.199.15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00408-016-9952-6","article-title":"Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976\u20132013","volume":"195","author":"Ungprasert","year":"2017","journal-title":"Lung"},{"key":"2025090409225408000_20.3.199.16","first-page":"233","article-title":"Immune-Mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database","volume":"85","author":"Rajoriya","year":"2003","journal-title":"PMJ"},{"key":"2025090409225408000_20.3.199.17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MCP.0000000000000598","article-title":"Clustering of immune-mediated diseases in sarcoidosis","volume":"25","author":"Terwiel","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"2025090409225408000_20.3.199.18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01929860","article-title":"Beitrag zur Frage der \u201cSarkoide\u201d (Boeck), resp. der subkutanen nodul\u00e4ren Tuberkulide (Darier)","volume":"77","author":"Winkler","year":"1905","journal-title":"Arch. f. Dermat."},{"key":"2025090409225408000_20.3.199.19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF02008817","article-title":"\u00dcber eine \u201eFebris uveo-parotidea subchronica\u201c, an der Glandula parotis und der Uvea des Auges lokalisiert und h\u00e4ufig mit Paresen cerebrospinaler Nerven kompliziert","volume":"70","author":"Heerford","year":"1909","journal-title":"Graefes Arhiv f\u00fcr Ophthalmologie"},{"key":"2025090409225408000_20.3.199.20","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/71.4.451"},{"key":"2025090409225408000_20.3.199.21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.15.12.1147"},{"key":"2025090409225408000_20.3.199.22","first-page":"1169","article-title":"Neurological complications of sarcoidosis","volume":"60","author":"James","year":"1967","journal-title":"Proc R Soc Med"},{"key":"2025090409225408000_20.3.199.23","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1985.04060080095022"},{"key":"2025090409225408000_20.3.199.24","first-page":"99","article-title":"Neurological complications of sarcoidosis","volume":"26","author":"Chen","year":"1987","journal-title":"Clin Exp Neurol"},{"key":"2025090409225408000_20.3.199.25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-3-336"},{"key":"2025090409225408000_20.3.199.26","first-page":"457","article-title":"Central nervous system sarcoidosis","volume":"56","author":"Pentland","year":"1985","journal-title":"Q J Med"},{"key":"2025090409225408000_20.3.199.27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1600-0404.1986.tb03277.x","article-title":"Neurosarcoidosis: clinical presentations and course in 50 patients","volume":"73","author":"Oksanen","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"2025090409225408000_20.3.199.28","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199009000-00001"},{"key":"2025090409225408000_20.3.199.29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.112.1.220"},{"key":"2025090409225408000_20.3.199.30","first-page":"168","article-title":"Les atteintes neurologiques de la sarco\u00efdose","volume":"28","author":"Pavese","year":"1999","journal-title":"Presse Med"},{"key":"2025090409225408000_20.3.199.31","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/92.2.103"},{"key":"2025090409225408000_20.3.199.32","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.5.927"},{"key":"2025090409225408000_20.3.199.33","first-page":"118","article-title":"A prospective study of 32 patients with neurosarcoidosis","volume":"20","author":"Allen","year":"2003","journal-title":"Sarc Vasc Diffuse Lung Dis"},{"key":"2025090409225408000_20.3.199.34","doi-asserted-by":"publisher","DOI":"10.1159\/000076534"},{"key":"2025090409225408000_20.3.199.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2004.07.011"},{"key":"2025090409225408000_20.3.199.36","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.151977"},{"key":"2025090409225408000_20.3.199.37","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcp042"},{"key":"2025090409225408000_20.3.199.38","doi-asserted-by":"crossref","unstructured":"Kidd DP . Sarcoidosis of the central nervous system: clinical features, imaging and CSF results. J Neurol ;2018:1906.","DOI":"10.1007\/s00415-018-8928-2"},{"key":"2025090409225408000_20.3.199.39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00041327-200309000-00002","article-title":"Sarcoidosis of the anterior visual pathway: 24 new cases","volume":"23","author":"Frohman","year":"2003","journal-title":"J Neuroophthalmol"},{"key":"2025090409225408000_20.3.199.40","doi-asserted-by":"publisher","DOI":"10.1080\/08820530802007382"},{"key":"2025090409225408000_20.3.199.41","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000270"},{"key":"2025090409225408000_20.3.199.42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/01658107.2014.928826","article-title":"Isolated pupil-involving third nerve palsy as the first presentation of sarcoidosis","volume":"38","author":"Bansal","year":"2014","journal-title":"Neuro-Ophthalmology"},{"key":"2025090409225408000_20.3.199.43","first-page":"235","article-title":"Sudden hearing loss in sarcoidosis: otoneurological study and neuroradiological correlates","volume":"31","author":"Cama","year":"2011","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2025090409225408000_20.3.199.44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAO.0000000000000501","article-title":"Cranial base manifestations of neurosarcoidosis: a review of 305 patients","volume":"36","author":"Carlson","year":"2015","journal-title":"Otol Neurotol"},{"key":"2025090409225408000_20.3.199.45","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf027"},{"key":"2025090409225408000_20.3.199.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.01.014"},{"key":"2025090409225408000_20.3.199.47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/B978-0-444-52902-2.00027-8","article-title":"Sarcoidosis of the peripheral nervous system","volume":"115","author":"Said","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"2025090409225408000_20.3.199.48","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.10.1558"},{"key":"2025090409225408000_20.3.199.49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2169\/internalmedicine.49.2894","article-title":"Multifocal conduction blocks in sarcoid peripheral neuropathy","volume":"49","author":"Sawai","year":"2010","journal-title":"Intern. Med."},{"key":"2025090409225408000_20.3.199.50","doi-asserted-by":"crossref","unstructured":"Mattiassich G , Schubert H , Hutarew G , et al . A rare manifestation of sarcoidosis with sensomotoric neuropathy of the ulnar nerve as the only symptom. Case Reports 2012:bcr2012007430.doi:10.1136\/bcr-2012-007430","DOI":"10.1136\/bcr-2012-007430"},{"key":"2025090409225408000_20.3.199.51","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0b013e3181ae3be9"},{"key":"2025090409225408000_20.3.199.52","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21890"},{"key":"2025090409225408000_20.3.199.53","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410070213"},{"key":"2025090409225408000_20.3.199.54","doi-asserted-by":"publisher","DOI":"10.5414\/NPP27096"},{"key":"2025090409225408000_20.3.199.55","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/mus.24652","article-title":"Sarcoid polyneuropathy masquerading as chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Singhal","year":"2015","journal-title":"Muscle Nerve"},{"key":"2025090409225408000_20.3.199.56","article-title":"Small fibre neuropathy in sarcoidosis","volume":"2002","author":"Hoitsma","year":"2086","journal-title":"Lancet"},{"key":"2025090409225408000_20.3.199.57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.03.011","article-title":"Sarcoidosis-associated small fibre neuropathy in a large cohort: clinical aspects and response to IVIg and anti-TNF alpha treatment","volume":"26","author":"Tavee","year":"2017","journal-title":"Respir Med"},{"key":"2025090409225408000_20.3.199.58","first-page":"73","article-title":"Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab","volume":"23","author":"Hoitsma","year":"2006","journal-title":"Sarc Vasc Diffuse Lung Dis"},{"key":"2025090409225408000_20.3.199.59","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2014.892072"},{"key":"2025090409225408000_20.3.199.60","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.clineuro.2007.06.003","article-title":"Bell-Shaped sensory impairments of all modalities in a neurosarcoidosis patient","volume":"109","author":"Miura","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"2025090409225408000_20.3.199.61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jns.2009.03.005","article-title":"Truncal polyradiculopathy due to sarcoidosis","volume":"281","author":"Uzawa","year":"2009","journal-title":"J Neurol Sci"},{"key":"2025090409225408000_20.3.199.62","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-019-2065-0","article-title":"Neurosarcoidosis resulting in thoracic radiculopathy: a case report","volume":"13","author":"Hamodat","year":"2019","journal-title":"J Med Case Rep"},{"key":"2025090409225408000_20.3.199.63","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcs121"},{"key":"2025090409225408000_20.3.199.64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11102-015-0678-x","article-title":"Hypothalamic\u2013pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review","volume":"19","author":"Anthony","year":"2016","journal-title":"Pituitary"},{"key":"2025090409225408000_20.3.199.65","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.105811","article-title":"Sarcoidosis of the central nervous system: safety and efficacy of treatment, and experience of biological therapies","volume":"194","author":"Kidd","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"2025090409225408000_20.3.199.66","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(69)90086-0"},{"key":"2025090409225408000_20.3.199.67","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1962.04210050068008"},{"key":"2025090409225408000_20.3.199.68","doi-asserted-by":"crossref","unstructured":"Meyer JS , Foley JM , Campagna-Pinto D . Granulomatous angiitis of the meninges in sarcoidosis. Arch Neurol Psych 1952:587\u2013600.","DOI":"10.1001\/archneurpsyc.1953.02320290039005"},{"key":"2025090409225408000_20.3.199.69","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.20.3.400"},{"key":"2025090409225408000_20.3.199.70","doi-asserted-by":"publisher","DOI":"10.1159\/000116697"},{"key":"2025090409225408000_20.3.199.71","doi-asserted-by":"publisher","DOI":"10.1159\/000092924"},{"key":"2025090409225408000_20.3.199.72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/str.21.1.152b","article-title":"Neurosarcoidosis and stroke","volume":"21","author":"Corse","year":"1990","journal-title":"Stroke"},{"key":"2025090409225408000_20.3.199.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.surneu.2006.02.048"},{"key":"2025090409225408000_20.3.199.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.12.003"},{"key":"2025090409225408000_20.3.199.75","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2176\/nmc.38.566","article-title":"Moyamoya disease associated with pulmonary sarcoidosis \u2014Case Report\u2014","volume":"38","author":"Takenaka","year":"1998","journal-title":"Neurol Med Chir"},{"key":"2025090409225408000_20.3.199.76","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2009.45.1.50"},{"key":"2025090409225408000_20.3.199.77","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clineuro.2018.03.019","article-title":"Carotid arteritis causing amaurosis fugax and ischaemic cerebrovascular events in neurosarcoidosis","volume":"169","author":"Kidd","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"2025090409225408000_20.3.199.78","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2018.05.018","article-title":"Cerebrovascular manifestations in neurosarcoidosis: how common are they and does perivascular enhancement matter?","volume":"73","author":"Bathla","year":"2018","journal-title":"Clin Radiol"},{"key":"2025090409225408000_20.3.199.79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03783.x"},{"key":"2025090409225408000_20.3.199.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.05.030"},{"key":"2025090409225408000_20.3.199.81","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-015-0373-6","article-title":"Spinal cord hemorrhage in a patient with neurosarcoidosis on long-term corticosteroid therapy: case report","volume":"15","author":"Pegat","year":"2015","journal-title":"BMC Neurol"},{"key":"2025090409225408000_20.3.199.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.10.003"},{"key":"2025090409225408000_20.3.199.83","first-page":"2045","article-title":"Engorgement of deep medullary veins in neurosarcoidosis: a common yet underrecognized cerebrovascular finding on SWI","volume":"2018","author":"Zamora","year":"2050","journal-title":"AJNR"},{"key":"2025090409225408000_20.3.199.84","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181d5c6b4"},{"key":"2025090409225408000_20.3.199.85","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00415-011-6080-3","article-title":"Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients","volume":"258","author":"Sakushima","year":"2011","journal-title":"J Neurol"},{"key":"2025090409225408000_20.3.199.86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MAJ.0b013e3182808781","article-title":"Spinal cord neurosarcoidosis","volume":"347","author":"Sohn","year":"2014","journal-title":"Am J Med Sci"},{"key":"2025090409225408000_20.3.199.87","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00415-016-8092-5","article-title":"Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 biopsy-proven patients","volume":"263","author":"Durel","year":"2016","journal-title":"J Neurol"},{"key":"2025090409225408000_20.3.199.88","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"2025090409225408000_20.3.199.89","doi-asserted-by":"publisher","DOI":"10.1097\/01.nrl.0000159983.19068.21"},{"key":"2025090409225408000_20.3.199.90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000366199","article-title":"Clinically isolated neurosarcoidosis: a recommended diagnostic path","volume":"73","author":"Wegener","year":"2015","journal-title":"Eur Neurol"},{"key":"2025090409225408000_20.3.199.91","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e3182704d04"},{"key":"2025090409225408000_20.3.199.92","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9100243","article-title":"Value of multimodal imaging approach to diagnosis of neurosarcoidosis","volume":"9","author":"Sammarra","year":"2019","journal-title":"Brain Sci"},{"key":"2025090409225408000_20.3.199.93","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182684672","article-title":"Mri and PET imaging discordance in neurosarcoidosis","volume":"79","author":"Huang","year":"2012","journal-title":"Neurology"},{"key":"2025090409225408000_20.3.199.94","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.ejim.2011.08.019","article-title":"Neurosarcoidosis: report of 30 cases and a literature survey","volume":"22","author":"Gascon-Bayarri","year":"2011","journal-title":"Eur J Int Med"},{"key":"2025090409225408000_20.3.199.95","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003277","article-title":"Neurosarcoidosis in a tertiary referral center: a cross-sectional cohort study","volume":"95","author":"Leonhard","year":"2016","journal-title":"Medicine"},{"key":"2025090409225408000_20.3.199.96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.09.008"},{"key":"2025090409225408000_20.3.199.97","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/17476348.2019.1655401","article-title":"New concepts in the pathogenesis of sarcoidosis","volume":"13","author":"Bennett","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2025090409225408000_20.3.199.98","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2016.1196135"},{"key":"2025090409225408000_20.3.199.99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/8565423","article-title":"Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6","volume":"2019","author":"Bergantini","year":"2019","journal-title":"Dis Markers"},{"key":"2025090409225408000_20.3.199.100","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/ene.13975","article-title":"The cerebrospinal fluid CD4\/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study","volume":"26","author":"Chazal","year":"2019","journal-title":"Eur J Neurol"},{"key":"2025090409225408000_20.3.199.101","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00415-019-09270-8","article-title":"Granulomatous CNS inflammation associated with seminoma","volume":"266","author":"Massey","year":"2019","journal-title":"J Neurol"},{"key":"2025090409225408000_20.3.199.102","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarc Vasc Diffuse Lung Dis"},{"key":"2025090409225408000_20.3.199.103","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","article-title":"Definition and consensus diagnostic criteria for neurosarcoidosis from the neurosarcoidosis Consortium consensus group","volume":"75","author":"Stern","year":"2018","journal-title":"JAMA Neurol"},{"key":"2025090409225408000_20.3.199.104","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12016-015-8492-9","article-title":"Treatment of sarcoidosis","volume":"49","author":"Baughman","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025090409225408000_20.3.199.105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000003431","article-title":"Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil","volume":"87","author":"Bitoun","year":"2016","journal-title":"Neurology"},{"key":"2025090409225408000_20.3.199.106","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jamaneurol.2017.2492","article-title":"Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis","volume":"74","author":"Joubert","year":"2017","journal-title":"JAMA Neurol"},{"key":"2025090409225408000_20.3.199.107","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/1744666X.2016.1175301","article-title":"Biologic therapies in the treatment of sarcoidosis","volume":"12","author":"Saketkoo","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"2025090409225408000_20.3.199.108","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","article-title":"Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients","volume":"47","author":"Jamilloux","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2025090409225408000_20.3.199.109","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8444-9"},{"key":"2025090409225408000_20.3.199.110","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","article-title":"Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series","volume":"89","author":"Gelfand","year":"2017","journal-title":"Neurology"},{"key":"2025090409225408000_20.3.199.111","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00415-019-09234-y","article-title":"Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment","volume":"266","author":"Riller","year":"2019","journal-title":"J Neurol"},{"key":"2025090409225408000_20.3.199.112","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2009.01518.x"},{"key":"2025090409225408000_20.3.199.113","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00055213"},{"key":"2025090409225408000_20.3.199.114","doi-asserted-by":"crossref","unstructured":"Kidd DP , Galloway M , Wilhelm T . Relapse of severe neurosarcoidosis with switch from originator infliximab to biosimilar. Neurology . doi:doi:10.1212\/WNL.0000000000009526. [Epub ahead of print: 11 May 2020].","DOI":"10.1212\/WNL.0000000000009526"},{"key":"2025090409225408000_20.3.199.115","first-page":"91","article-title":"Practical eminence and experience-based recommendations for use of TNF-alpha inhibitors in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarc Vasc Diffuse Lung Dis"},{"key":"2025090409225408000_20.3.199.116","article-title":"Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents","volume":"1","author":"Sharp","year":"2019","journal-title":"Respir Med"},{"key":"2025090409225408000_20.3.199.117","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418805732","article-title":"Successful therapy with rituximab in three patients with probable neurosarcoidosis","volume":"11","author":"Zella","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"2025090409225408000_20.3.199.118","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00000914"},{"key":"2025090409225408000_20.3.199.119","first-page":"4237","article-title":"Identification of JAK-STAT signalling involvement in sarcoidosis severity via a novel micro-RNA-regulated peripheral blood mononuclear cell gene signature","volume":"26","author":"ZhouT","year":"2017","journal-title":"Sci Rep"},{"key":"2025090409225408000_20.3.199.120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805958"},{"key":"2025090409225408000_20.3.199.121","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3655"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/practneurol-2019-002349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T16:23:13Z","timestamp":1757002993000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/practneurol-2019-002349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":121,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6,2]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/practneurol-2019-002349"],"URL":"https:\/\/doi.org\/10.1136\/practneurol-2019-002349","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}